Giuseppina Catanzaro | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Extra-Cellular Vesicles Derived from Thyroid Cancer Cells Promote the Epithelial to Mesenchymal Transition (EMT) and the Transfer of Malignant Phenotypes through Immune Mediated Mechanisms	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES	2023
New Advances in Metabolic Syndrome, from Prevention to Treatment: The Role of Diet and Food	NUTRIENTS	2023
Hedgehog-GLI and Notch Pathways Sustain Chemoresistance and Invasiveness in Colorectal Cancer and Their Inhibition Restores Chemotherapy Efficacy	CANCERS	2023
Prospective validation study of a novel integrated pathway based on clinical features, MRI biomarkers and microRNAs for early detection of prostate cancer	EUROPEAN UROLOGY ONCOLOGY	2023
Non-Coding RNAs in Health and Disease: Editorial	BIOMEDICINES	2023
Nanoparticles for Drug and Gene Delivery in Pediatric Brain Tumors’ Cancer Stem Cells: Current Knowledge and Future Perspectives	PHARMACEUTICS	2023
Molecular mechanisms of the tyrosine kinase inhibitor pralsetinib activity in in-vitro models of medullary thyroid carcinoma: Aberrant activation of the HH-Gli signaling pathway in acquired resistance	BIOMÉDECINE & PHARMACOTHÉRAPIE	2023
Network analysis identifies circulating miR-155 as predictive biomarker of type 2 diabetes mellitus development in obese patients: a pilot study	SCIENTIFIC REPORTS	2023
Circulating cell-free DNA (cfDNA) in patients with medullary thyroid carcinoma is characterized by specific fragmentation and methylation changes with diagnostic value	BIOMARKER RESEARCH	2023
The endocrine disruptor cadmium modulates the androgen-estrogen receptors ratio and induces inflammatory cytokines in luminal (A) cell models of breast cancer	ENDOCRINE	2023
Hypocalcemia in combination with hyperphosphatemia impairs muscle cell differentiation in vitro	JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION	2023
MicroRNA loaded edible nanoparticles: an emerging personalized therapeutic approach for the treatment of obesity and metabolic disorders	THERANOSTICS	2022
Identification and Validation of miR-222-3p and miR-409-3p as Plasma Biomarkers in Gestational Diabetes Mellitus Sharing Validated Target Genes Involved in Metabolic Homeostasis	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES	2022
{MEDB}-09. Unraveling the role of unfolded protein response in medulloblastoma cancer stem cells	NEURO-ONCOLOGY	2022
MiR-1248: a new prognostic biomarker able to identify supratentorial hemispheric pediatric low-grade gliomas patients associated with progression	BIOMARKER RESEARCH	2022
A novel microRNA signature for the detection of melanoma by liquid biopsy	JOURNAL OF TRANSLATIONAL MEDICINE	2022
Network analysis integrating microRNA expression profiling with MRI biomarkers and clinical data for prostate cancer early detection: a proof of concept study	BIOMEDICINES	2021
Upfront treatment with mTOR inhibitor everolimus in pediatric low-grade gliomas: A single-center experience	INTERNATIONAL JOURNAL OF CANCER	2021
Pediatric low-grade gliomas: molecular characterization of patient-derived cellular models	CHILDS NERVOUS SYSTEM	2020
BRAF mutant colorectal cancer: ErbB2 expression levels as predictive factor for the response to combined BRAF/ErbB inhibitors	BMC CANCER	2020

Progetti di Ricerca

MicroRNAs in pediatric low-grade gliomas (pLGGs): new opportunities in disease management

Gruppi di ricerca

Gestational diabetes; Risk Factors; Outcomes